Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen Therapy in Non-severe COVID-19
NCT04539626Unknown
- Sponsor
- Centro Médico Nacional 20 de Noviembre
- Start
- Oct 2020
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of ethinyl estradiol in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Centro Médico Nacional 20 de Noviembre. Primary endpoint: Clinical improve to estrogen therapy in non-severe COVID-19 patients at Day 21. Status: unknown.
02
Drugs
ethinyl estradiol
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04539626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04539626.